Skip to main content
Erschienen in: Surgical Endoscopy 8/2011

01.08.2011

The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis

verfasst von: Young-Mi Park, Eun Cho, Hye-Young Kang, Jong-Mann Kim

Erschienen in: Surgical Endoscopy | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic submucosal dissection (ESD) allows en bloc resection of the entire lesion, permitting a higher curative resection rate and increased quality of life by minimizing the resection size compared with that of endoscopic mucosal resection (EMR). Although ESD has been implemented at most university hospitals in Korea, potential complications of ESD such as bleeding and perforation raise doubts in the therapeutic decision on use of the ESD procedure for early gastric cancer patients and in reimbursement decision making. This systematic review aimed to address both the effectiveness and safety outcomes of ESD versus EMR for early gastric cancer.

Methods

MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and Koreamed were searched using the primary keywords “stomach neoplasm” AND “endoscopic submucosal dissection” AND “endoscopic mucosal resection.” To assess the quality of selected studies, the methodologic approach of the Scottish Intercollegiate Guidelines Network was used. Five effectiveness-relevant and three safety-relevant outcome measures were extracted. Bibliography management and metaanalysis for each outcome were conducted using Review Manager 5.0.

Results

Three nonconcurrent cohort studies and nine retrospective cohort studies were identified. Metaanalyses showed ESD to be significantly more effective than EMR for en bloc resection (odds ratio [OR], 8.43; 95% confidence interval [CI], 5.20–13.67), complete resection (OR, 14.11; 95% CI, 10.85–18.35), curative resection (OR, 3.28; 95% CI, 1.95–5.54), and local recurrence (risk ratio [RR], 0.13; 95% CI, 0.04–0.41). Whereas intraoperative bleeding (RR, 2.16; 95% CI, 1.14–4.09), perforation risk (RR, 3.58; 95% CI, 1.95–6.55), and operation time (standard mean difference [SMD], 1.55; 95% CI, 0.74–2.37) were significantly greater for ESD, overall bleeding risk (RR, 1.22; 95% CI, 0.76–1.98) and all-cause mortality (RR, 0.65; 95% CI, 0.08–5.38) did not differ significantly between ESD and EMR.

Conclusions

Considering that bleeding risk did not differ significantly between ESD and EMR and that perforation risk usually does not lead to life-threatening disease, the effectiveness benefit of ESD can outweigh the overall harm compared with EMR on the condition that ESD is performed by experienced practitioners.
Literatur
1.
Zurück zum Zitat Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M (1992) Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer 70:1030–1037PubMedCrossRef Nakamura K, Ueyama T, Yao T, Xuan ZX, Ambe K, Adachi Y, Yakeishi Y, Matsukuma A, Enjoji M (1992) Pathology and prognosis of gastric carcinoma: findings in 10,000 patients who underwent primary gastrectomy. Cancer 70:1030–1037PubMedCrossRef
2.
Zurück zum Zitat Kang KJ, Lee JH (2010) Characteristics of gastric cancer in Korea—with an emphasis on the increase of the early gastric cancer (EGC). J Korean Med Assoc 53:283–289CrossRef Kang KJ, Lee JH (2010) Characteristics of gastric cancer in Korea—with an emphasis on the increase of the early gastric cancer (EGC). J Korean Med Assoc 53:283–289CrossRef
3.
Zurück zum Zitat Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S (2001) Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48:225–229PubMedCrossRef Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, Hosokawa K, Shimoda T, Yoshida S (2001) Endoscopic mucosal resection for treatment of early gastric cancer. Gut 48:225–229PubMedCrossRef
4.
Zurück zum Zitat Jung HY (2008) Extended approach of EMR/ESD in stomach cancer. J Korean Gastric Cancer Assoc 8:5–8 Jung HY (2008) Extended approach of EMR/ESD in stomach cancer. J Korean Gastric Cancer Assoc 8:5–8
5.
Zurück zum Zitat Hotta K, Oyama T, Akamatsu T, Tomori A, Hasebe O, Nakamura N, Kojima E, Suga T, Miyabayashi H, Ohta H (2010) A comparison of outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasms between high-volume and low-volume centers: multicenter retrospective questionnaire study conducted by the Nagano ESD study group. Intern Med 49:253–259PubMedCrossRef Hotta K, Oyama T, Akamatsu T, Tomori A, Hasebe O, Nakamura N, Kojima E, Suga T, Miyabayashi H, Ohta H (2010) A comparison of outcomes of endoscopic submucosal dissection (ESD) for early gastric neoplasms between high-volume and low-volume centers: multicenter retrospective questionnaire study conducted by the Nagano ESD study group. Intern Med 49:253–259PubMedCrossRef
6.
Zurück zum Zitat Sumiyama K, Kaise M, Nakayoshi T, Kato M, Mashiko T, Uchiyama Y, Goda K, Hino S, Nakamura Y, Matsuda K, Mochizuki K, Kawamura M, Tajiri H (2004) Combined use of a magnifying endoscope with a narrow band imaging system and a multibending endoscope for en bloc EMR of early-stage gastric cancer. Gastrointest Endosc 60:79–84PubMedCrossRef Sumiyama K, Kaise M, Nakayoshi T, Kato M, Mashiko T, Uchiyama Y, Goda K, Hino S, Nakamura Y, Matsuda K, Mochizuki K, Kawamura M, Tajiri H (2004) Combined use of a magnifying endoscope with a narrow band imaging system and a multibending endoscope for en bloc EMR of early-stage gastric cancer. Gastrointest Endosc 60:79–84PubMedCrossRef
7.
Zurück zum Zitat Jang JS, Lee EJ, Lee SW, Lee JH, Roh MH, Han SY, Choi SR, Jeong JS (2007) Endoscopic submucosal dissection for early gastric cancer and gastric adenoma. Korean J Gastroenterol 49:356–363PubMed Jang JS, Lee EJ, Lee SW, Lee JH, Roh MH, Han SY, Choi SR, Jeong JS (2007) Endoscopic submucosal dissection for early gastric cancer and gastric adenoma. Korean J Gastroenterol 49:356–363PubMed
8.
Zurück zum Zitat Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, Hwangbo Y, Keum BR, Park JJ, Chun HJ, Kim HJ, Kim JJ, Ji SR, Seol SY (2009) Therapeutic outcomes in 1,000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD study group multicenter study. Gastrointest Endosc 69:1228–1235PubMedCrossRef Chung IK, Lee JH, Lee SH, Kim SJ, Cho JY, Cho WY, Hwangbo Y, Keum BR, Park JJ, Chun HJ, Kim HJ, Kim JJ, Ji SR, Seol SY (2009) Therapeutic outcomes in 1,000 cases of endoscopic submucosal dissection for early gastric neoplasms: Korean ESD study group multicenter study. Gastrointest Endosc 69:1228–1235PubMedCrossRef
9.
Zurück zum Zitat Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F (2009) Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 41:751–757PubMedCrossRef Cao Y, Liao C, Tan A, Gao Y, Mo Z, Gao F (2009) Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract. Endoscopy 41:751–757PubMedCrossRef
10.
Zurück zum Zitat Hirasaki S, Kanzaki H, Matsubara M, Fujita K, Matsumura S, Suzuki S (2008) Treatment of gastric remnant cancer postdistal gastrectomy by endoscopic submucosal dissection using an insulation-tipped diathermic knife. World J Gastroenterol 14:2550–2555PubMedCrossRef Hirasaki S, Kanzaki H, Matsubara M, Fujita K, Matsumura S, Suzuki S (2008) Treatment of gastric remnant cancer postdistal gastrectomy by endoscopic submucosal dissection using an insulation-tipped diathermic knife. World J Gastroenterol 14:2550–2555PubMedCrossRef
11.
Zurück zum Zitat Hoteya S, Iizuka T, Kikuchi D, Yahagi N (2010) Clinical advantages of endoscopic submucosal dissection for gastric cancers in remnant stomach surpass conventional endoscopic mucosal resection. Dig Endosc 22:17–20PubMedCrossRef Hoteya S, Iizuka T, Kikuchi D, Yahagi N (2010) Clinical advantages of endoscopic submucosal dissection for gastric cancers in remnant stomach surpass conventional endoscopic mucosal resection. Dig Endosc 22:17–20PubMedCrossRef
12.
Zurück zum Zitat Oda I, Saito D, Tada M, Iishi H, Tanabe S, Oyama T, Doi T, Otani Y, Fujisaki J, Ajioka Y, Hamada T, Inoue H, Gotoda T, Yoshida S (2006) A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 9:262–270PubMedCrossRef Oda I, Saito D, Tada M, Iishi H, Tanabe S, Oyama T, Doi T, Otani Y, Fujisaki J, Ajioka Y, Hamada T, Inoue H, Gotoda T, Yoshida S (2006) A multicenter retrospective study of endoscopic resection for early gastric cancer. Gastric Cancer 9:262–270PubMedCrossRef
13.
Zurück zum Zitat Min BH, Lee JH, Kim JJ, Shim SG, Chang DK, Kim YH, Rhee PL, Kim KM, Park CK, Rhee JC (2009) Clinical outcomes of endoscopic submucosal dissection (ESD) for treating early gastric cancer: comparison with endoscopic mucosal resection after circumferential precutting (EMR-P). Dig Liver Dis 41:201–209PubMedCrossRef Min BH, Lee JH, Kim JJ, Shim SG, Chang DK, Kim YH, Rhee PL, Kim KM, Park CK, Rhee JC (2009) Clinical outcomes of endoscopic submucosal dissection (ESD) for treating early gastric cancer: comparison with endoscopic mucosal resection after circumferential precutting (EMR-P). Dig Liver Dis 41:201–209PubMedCrossRef
14.
Zurück zum Zitat Catalano F, Trecca A, Rodella L, Lombardo F, Tomezzoli A, Battista S, Silano M, Gaj F, de Manzoni G (2009) The modern treatment of early gastric cancer: our experience in an Italian cohort. Surg Endosc 23:1581–1586PubMedCrossRef Catalano F, Trecca A, Rodella L, Lombardo F, Tomezzoli A, Battista S, Silano M, Gaj F, de Manzoni G (2009) The modern treatment of early gastric cancer: our experience in an Italian cohort. Surg Endosc 23:1581–1586PubMedCrossRef
15.
Zurück zum Zitat Yokoi C, Gotoda T, Hamanaka H, Oda I (2006) Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection. Gastrointest Endosc 64:212–218PubMedCrossRef Yokoi C, Gotoda T, Hamanaka H, Oda I (2006) Endoscopic submucosal dissection allows curative resection of locally recurrent early gastric cancer after prior endoscopic mucosal resection. Gastrointest Endosc 64:212–218PubMedCrossRef
16.
Zurück zum Zitat Hoteya S, Iizuka T, Kikuchi D, Yahagi N (2009) Benefits of endoscopic submucosal dissection according to size and location of gastric neoplasm, compared with conventional mucosal resection. J Gastroenterol Hepatol 24:1102–1106PubMedCrossRef Hoteya S, Iizuka T, Kikuchi D, Yahagi N (2009) Benefits of endoscopic submucosal dissection according to size and location of gastric neoplasm, compared with conventional mucosal resection. J Gastroenterol Hepatol 24:1102–1106PubMedCrossRef
17.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558PubMedCrossRef
18.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188PubMedCrossRef
19.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMed Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634PubMed
20.
Zurück zum Zitat Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, Yoshihara M, Chayama K (2006) Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc 64:877–883PubMedCrossRef Oka S, Tanaka S, Kaneko I, Mouri R, Hirata M, Kawamura T, Yoshihara M, Chayama K (2006) Advantage of endoscopic submucosal dissection compared with EMR for early gastric cancer. Gastrointest Endosc 64:877–883PubMedCrossRef
21.
Zurück zum Zitat Watanabe K, Ogata S, Kawazoe S, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M, Tsunada S, Iwakiri R, Fujimoto K (2006) Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc 63:776–782PubMedCrossRef Watanabe K, Ogata S, Kawazoe S, Koyama T, Kajiwara T, Shimoda Y, Takase Y, Irie K, Mizuguchi M, Tsunada S, Iwakiri R, Fujimoto K (2006) Clinical outcomes of EMR for gastric tumors: historical pilot evaluation between endoscopic submucosal dissection and conventional mucosal resection. Gastrointest Endosc 63:776–782PubMedCrossRef
22.
Zurück zum Zitat Choi KS, Jung HY, Choi KD, Chung JW, Oh TH, Jo JY, Song HJ, Lee GH, Byeon JS, Myung SJ, Yang SK, Kim JH (2006) Endoscopic submucosal dissection for gastric tumors: complete resection rate, resection time, and complications in comparison with endoscopic mucosal resection after circumferential mucosal incision with a needle knife. Korean J Gastrointest Endosc 32:326–332 Choi KS, Jung HY, Choi KD, Chung JW, Oh TH, Jo JY, Song HJ, Lee GH, Byeon JS, Myung SJ, Yang SK, Kim JH (2006) Endoscopic submucosal dissection for gastric tumors: complete resection rate, resection time, and complications in comparison with endoscopic mucosal resection after circumferential mucosal incision with a needle knife. Korean J Gastrointest Endosc 32:326–332
23.
Zurück zum Zitat Shimura T, Sasaki M, Kataoka H, Tanida S, Oshima T, Ogasawara N, Wada T, Kubota E, Yamada T, Mori Y, Fujita F, Nakao H, Ohara H, Inukai M, Kasugai K, Joh T (2007) Advantages of endoscopic submucosal dissection over conventional endoscopic mucosal resection. J Gastroenterol Hepatol 22:821–826PubMedCrossRef Shimura T, Sasaki M, Kataoka H, Tanida S, Oshima T, Ogasawara N, Wada T, Kubota E, Yamada T, Mori Y, Fujita F, Nakao H, Ohara H, Inukai M, Kasugai K, Joh T (2007) Advantages of endoscopic submucosal dissection over conventional endoscopic mucosal resection. J Gastroenterol Hepatol 22:821–826PubMedCrossRef
24.
Zurück zum Zitat Nakamoto S, Sakai Y, Kasanuki J, Kondo F, Ooka Y, Kato K, Arai M, Suzuki T, Matsumura T, Bekku D, Ito K, Tanaka T, Yokosuka O (2009) Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy 41:746–750PubMedCrossRef Nakamoto S, Sakai Y, Kasanuki J, Kondo F, Ooka Y, Kato K, Arai M, Suzuki T, Matsumura T, Bekku D, Ito K, Tanaka T, Yokosuka O (2009) Indications for the use of endoscopic mucosal resection for early gastric cancer in Japan: a comparative study with endoscopic submucosal dissection. Endoscopy 41:746–750PubMedCrossRef
25.
Zurück zum Zitat Yamaguchi Y, Katusmi N, Aoki K, Toki M, Nakamura K, Abe N, Morozumi K, Sugiyama M, Ishida H, Takahashi S (2007) Resection area of 15 mm as dividing line for choosing strip biopsy or endoscopic submucosal dissection for mucosal gastric neoplasm. J Clin Gastroenterol 41:472–476PubMedCrossRef Yamaguchi Y, Katusmi N, Aoki K, Toki M, Nakamura K, Abe N, Morozumi K, Sugiyama M, Ishida H, Takahashi S (2007) Resection area of 15 mm as dividing line for choosing strip biopsy or endoscopic submucosal dissection for mucosal gastric neoplasm. J Clin Gastroenterol 41:472–476PubMedCrossRef
26.
Zurück zum Zitat Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226PubMedCrossRef Ohkuwa M, Hosokawa K, Boku N, Ohtu A, Tajiri H, Yoshida S (2001) New endoscopic treatment for intramucosal gastric tumors using an insulated-tip diathermic knife. Endoscopy 33:221–226PubMedCrossRef
Metadaten
Titel
The effectiveness and safety of endoscopic submucosal dissection compared with endoscopic mucosal resection for early gastric cancer: a systematic review and metaanalysis
verfasst von
Young-Mi Park
Eun Cho
Hye-Young Kang
Jong-Mann Kim
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Surgical Endoscopy / Ausgabe 8/2011
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-011-1627-z

Weitere Artikel der Ausgabe 8/2011

Surgical Endoscopy 8/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.